Clinical Trials Browser

Interventional × Neoadjuvant Therapy × 30 days × Clear all

NCT07608159 2026-05-27

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT01272037 2026-05-26

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Phase 3 Active not recruiting

5,018 enrolled 14 charts

Carcinoma, Intraductal, Noninfiltrating

NCT06788912 2026-05-26

MK-3475-01E

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT04031677 2026-05-22

STRASS2

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07589972 2026-05-15

Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer

Phase NA Not yet recruiting

Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer

NCT05296746 2026-05-14

RIBOLARIS

Phase 2 Active not recruiting

Breast Neoplasms

NCT07581405 2026-05-12

GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT02296684 2026-05-08

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

67 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07149857 2026-05-08

CARTITUDE-10

Phase 2 Recruiting

Multiple Myeloma

NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT06290687 2026-05-07

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT06386887 2026-05-07

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

Phase NA Recruiting

Carcinoma, Ovarian Epithelial, Intermittent Fasting

NCT07570368 2026-05-06

Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasms, Stress, Psychological

NCT06417190 2026-05-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Phase 2 Recruiting

Neoplasms